Recent Updates
Recently added Catalysts
LXRX

Lexicon Announces Pricing of $85.0 Million Public Offering and Concurrent Private Placement

Key Takeaway: Lexicon Announces Pricing of $85.0 Million Public Offering and Concurrent Private Placement
Price reaction · baseline $3.27 (2022-07-27 close) · hit after-hours · 2 other LXRX headline(s) in the window, move may be shared
day 0 close
-26.6%
day 1 · peak
-27.2%
day 3
-20.5%

BiopharmaWatch Analysis

From our catalyst data and publicly available data · not financial advice
Best trade, last catalyst
+111%
120-day peak, hindsight
Typical move
11%
average across 13 past catalysts
Cash runway
~61 mo
Minimal dilution risk
Lead asset
Sotagliflozin
Phase 3 · Type 1 Diabetes Mellitus

Full Press Release Details

Lexicon Announces Pricing of $85.0 Million Public Offering and Concurrent Private Placement.
Last updated: Jul 28, 2022